| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Enhancing oral contraceptive success: the potential of new formulations |
Kaunitz, A.M.; |
American Journal of Obstetrics and Gynecology |
2004-04-01 |
查看 |
| Oral contraceptives and premenstrual symptoms: Comparison of a 21/7 andextended regimen |
Coffee, A.L.;Kuehl, T.J.;Willis, S.;Sulak, P.J.; |
American Journal of Obstetrics and Gynecology |
2006-11-01 |
查看 |
| Clinical and metabolic effects of medroxyprogesterone acetate andethinyl estradiol plus drospirenone in women with polycystic ovary syndrome |
Ozdemir, S.;Gorkemli, H.;Gezginc, K.;Ozdemir, M.;Kiyici, A.; |
International Journal of Gynecology & Obstetrics |
2008-10-01 |
查看 |
| Ethinyl estradiol 20@mg/drospirenone 3mg 24/4 oral contraceptive forthe treatment of functional impairment in women with premenstrual dysphoricdisorder |
Marr, J.;Heinemann, K.;Kunz, M.;Rapkin, A.; |
International Journal of Gynecology & Obstetrics |
2011-05-01 |
查看 |
| Contraceptive efficacy of a combined oral contraceptive containingethinyloestradiol 20@mg/drospirenone 3mg administered in a 24/4 regimen: apooled analysis of four open-label studies |
Anttila, L.;Bachmann, G.;Hernadi, L.;Kunz, M.;Marr, J.;Klipping, C.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2011-04-01 |
查看 |
| Treatment of moderate acne vulgaris using a combined oral contraceptivecontaining ethinylestradiol 20@mg plus drospirenone 3mg administered in a24/4 regimen: a pooled analysis |
Koltun, W.;Maloney, J.M.;Marr, J.;Kunz, M.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2011-04-01 |
查看 |
| Estradiol plus drospirenone therapy increases mammographic breastdensity in perimenopausal women |
Kiran, H.;Tok, A.;Yuksel, M.;Arikan, D.C.;Ekerbicer, H.C.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2011-12-01 |
查看 |
| Estradiol plus drospirenone therapy increases mammographic breastdensity in perimenopausal women |
Kiran, H.;Tok, A.;Yuksel, M.;Arikan, D.C.;Ekerbicer, H.C.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2011-12-01 |
查看 |
| A historical cycle control comparison of two drospirenone-containingcombined oral contraceptives: ethinylestradiol 30@mg/drospirenone 3mgadministered in a 21/7 regimen versus ethinylestradiol 20@mg/drospirenone3mg administered in a 24/4 regimen |
Marr, J.;Gerlinger, C.;Kunz, M.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2012-05-01 |
查看 |
| Hyperandrogenic women treated with a continuous-regimen oralcontraceptive |
Caruso, S.;Cianci, S.;Malandrino, C.;Cicero, C.;Presti, L.L.;Cianci, A.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2013-12-01 |
查看 |
| Influence of an oral contraceptive containing drospirenone on insulinsensitivity of healthy women |
Cagnacci, A.;Piacenti, I.;Zanin, R.;Xholli, A.;Tirelli, A.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2014-07-01 |
查看 |
| Comparison of two contraceptive pills containing drospirenone and 20@mgor 30@mg ethinyl estradiol for polycystic ovary syndrome |
Bhattacharya, S.M.;Jha, A.;DasMukhopadhyay, L.; |
International Journal of Gynecology & Obstetrics |
2016-02-01 |
查看 |
| Calcium versus oral contraceptive pills containing drospirenone for thetreatment of mild to moderate premenstrual syndrome: a double blindrandomized placebo controlled trial |
Shehata, N.A.A.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2016-03-01 |
查看 |
|
|
